For instance, Han et al. focused on the TCR repertoire of TCD8+PD-1+ cells of NSCLC patients that were treated with anti-PD-1 or anti-PD-L1 ICIs [130]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.